霍奇金淋巴瘤武器库中的新兴免疫疗法
Michael A Spinner1, Ranjana H Advani2
1Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, CA, USA.
Expert opinion on emerging drugs
|April 27, 2024
概括
新型免疫疗法对经典霍奇金淋巴瘤 (cHL) 患者有希望,这些患者在布伦图西马布维多丁和PD-1抑制剂后复发. 新兴药物和组合旨在改善治疗结果.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
背景情况:
- 经典霍奇金淋巴瘤 (cHL) 的结果已经改善了布伦图西马布维多丁和PD-1抑制剂.
- 在这些治疗后复发的患者中,对有效治疗的需求尚未得到满足.
- 了解cHL生物学方面的进步刺激了新型治疗策略的开发.
研究的目的:
- 审查新兴的免疫治疗剂和cHL的组合.
- 突出针对复发性或耐药性cHL患者正在开发的新疗法.
- 提供关于cHL免疫疗法的当前景观和未来方向的概述.
主要方法:
- 对涉及新型PD-1/PD-L1抑制剂,CTLA-4,LAG-3,TIM-3,TIGIT和CD47/SIRPα抑制剂的临床试验的审查.
- 对各种免疫治疗剂和组合的已发表的第1-2期研究数据的分析.
- 包括正在进行的试验,包括第一个PD-1抑制剂耐火性cHL的第3期试验.
主要成果:
- 一个强大的新型免疫疗法管道正在开发中,用于cHL.
- 新兴药物包括新型检查点抑制剂,抗体-药物联合体,双特异性抗体和细胞疗法 (CAR-T,NK细胞).
- 目前正在评估早期研究的关键安全性和有效性数据.
结论:
- 新型免疫疗法在治疗CHL方面具有显著的前景.
- 理性组合和下一代构造可能会提高响应率和耐用性.
- 生物标志物识别和敏感反应评估工具对于cHL的精准医学至关重要.
相关概念视频
01:27Tumor Immunotherapy
520
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
520
01:30Cancer Vaccines
359
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
359
01:27Cytotoxic T Cells-mediated Immune Response
903
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
903